Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-24-000314
Filing Date
2024-11-21
Accepted
2024-11-21 13:35:56
Documents
28
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1119form10q.htm   iXBRL 10-Q 241072
2 EXHIBIT 31.1 skin1119form10qexh31_1.htm EX-31.1 8247
3 EXHIBIT 31.2 skin1119form10qexh31_2.htm EX-31.2 8334
4 EXHIBIT 32.1 skin1119form10qexh32_1.htm EX-32.1 3948
  Complete submission text file 0001554795-24-000314.txt   1115036

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20240930.xsd EX-101.SCH 8232
6 XBRL CALCULATION FILE skin-20240930_cal.xml EX-101.CAL 17606
7 XBRL DEFINITION FILE skin-20240930_def.xml EX-101.DEF 9602
8 XBRL LABEL FILE skin-20240930_lab.xml EX-101.LAB 91372
9 XBRL PRESENTATION FILE skin-20240930_pre.xml EX-101.PRE 64017
31 EXTRACTED XBRL INSTANCE DOCUMENT skin1119form10q_htm.xml XML 69032
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 241483406
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)